Midakla
(Daclatasvir)
(60 mg)
(28)
(Tablets)
Midakla (daclatasvir) 60 mg 28 tab. NATCO, India
Article:
In Stock
Indications:
Midakla is indicated for the treatment of viral hepatitis C 1, 2, 3 and 4 genotypes in adults.
Application:
usual dose - 60 mg 1 time per day
Interchangeable analogues:
Natdak
Daclatasvir
Ducklinza
-
Commercial name:Midakla
-
Сhemical name:Daclatasvir
-
Dosage:60 mg
-
Quantity:28
-
Release form:Tablets
No reviews yet